Literature DB >> 31517762

Intraocular Degradation of XEN45 Gel Stent 3 Years After its Implantation.

Randolf A Widder1,2, Pia Kühnrich1, Matthias Hild1, Corinna Rennings1, Alexander Szumniak1, Gernot F Rössler1,3.   

Abstract

INTRODUCTION: We report a case of XEN45 Gel Stent removal 3 years after its implantation. The stent had degraded with a closed lumen, so a new stent was implanted. CASE REPORT: A 63-year-old woman was scheduled for XEN45 Gel Stent implantation. Three years after the primary surgery and 2 years after a surgical revision, second revision surgery was required. The conjunctiva was opened, and the implanted XEN Gel Stent was stripped of the adhesive scar tissues. No aqueous humor flow was seen through the stent, and therefore, the stent was removed. The intrascleral and intracameral parts had degraded. The surface of the stent was irregular and cobbled. A part of the lumen in the middle of the stent had closed. DISCUSSION: We detected changes in the stent after its removal during the surgical revision with conjunctival opening, which is our standard approach for failed XEN Gel Stents. Most surgeons advise needling of the stent in cases of failure. However, in cases of needling, changes in the stent might not have been detected. Thus, the number of patients with similar changes as this report might be higher than the publications suggest. No unique characteristics distinguished this patient from those who had a functional XEN Gel Stent. The stent, in this case, might have been of inferior quality as an exception, or all stents might degrade over time. Therefore, gonioscopy should be performed carefully to detect any changes in the stent. In cases of suspected stent degradation, we recommend a revision surgery with conjunctival opening and removal of the stent in cases of degradation.

Entities:  

Year:  2019        PMID: 31517762     DOI: 10.1097/IJG.0000000000001364

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  6 in total

1.  A retrospective review of XEN implant surgery: efficacy, safety and the effect of combined cataract surgery.

Authors:  Symeon Nicolaou; Tasneem Z Khatib; Zhiheng Lin; Twishaa Sheth; Golden Ogbonna; Lamia Hamidovic; Asad Zaheer; Chrysostomos Dimitriou
Journal:  Int Ophthalmol       Date:  2021-10-19       Impact factor: 2.031

2.  The use of polyisobutylene-based polymers in ophthalmology.

Authors:  Leonard Pinchuk
Journal:  Bioact Mater       Date:  2021-09-21

3.  Tissue Reactivity to, and Stability of, Glaucoma Drainage Device Materials Placed Under Rabbit Conjunctiva.

Authors:  Kenichi Nakamura; Tomokazu Fujimoto; Miho Okada; Kentaro Maki; Atsushi Shimazaki; Masatomo Kato; Toshihiro Inoue
Journal:  Transl Vis Sci Technol       Date:  2022-04-01       Impact factor: 3.283

4.  Outcomes of Deep Sclerectomy following Failed XEN Gel Stent Implantation in Open-Angle Glaucoma: A Prospective Study.

Authors:  Giorgio Enrico Bravetti; Kevin Gillmann; Harsha L Rao; André Mermoud; Kaweh Mansouri
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

5.  Comparing Medium-Term Clinical Outcomes following XEN® 45 and XEN® 63 Device Implantation.

Authors:  Aitor Fernández-García; Ying Zhou; Mercedes García-Alonso; Henry D Andrango; Francisco Poyales; Nuria Garzón
Journal:  J Ophthalmol       Date:  2020-03-23       Impact factor: 1.909

6.  Failure of XEN Gel Stent Implantation as a Stand-Alone Procedure in Congenital Glaucoma: Case Report of Secondary Congenital Glaucoma in Neurofibromatosis Type 1.

Authors:  Hannah Schellhase; Matthias Fuest; David Kuerten; Peter Walter; Niklas Plange
Journal:  Case Rep Ophthalmol Med       Date:  2021-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.